Dr Moira Cruickshank
Research Fellow
- 51cg
-
- Email Address
- m.cruickshank@abdn.ac.uk
- Office Address
Health Services Research Unit
3rd Floor Health Sciences Building
Foresterhill
Aberdeen
AB25 2ZD- School/Department
- School of Medicine, Medical Sciences and Nutrition
Biography
Moira Cruickshank is a Research Fellow in the Evidence Synthesis programme of ACE.
Moira was a Police Officer in the Metropolitan Police Service before returning to full time education at the 51cg in 2002, graduating with BSc (Hons) Psychology in 2006, MRes Psychology in 2007 and PhD Psychology in 2011. Since then, Moira has been a systematic reviewer within the Evidence Synthesis programme and is involved in technology assessment appraisals and health technology assessment reviews.
- Publications
-
Page 1 of 3 Results 1 to 25 of 56
Acalabrutinib with bendamustine and rituximab for untreated mantle cell lymphoma [ID6155]
Commissioned by National Institute for Health and Care Excellence (NICE). Aberdeen HTA GroupBooks and Reports: Commissioned Reports- [ONLINE]
Duration of wound coverage for the prevention of surgical site infections after surgery: A systematic review of current evidence with meta-analysis of randomised controlled trials
International Wound Journal, vol. 23, no. 5, e70943Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
What are the information and decision-support needs of women planning mode of birth in routine antenatal care in high-income countries? A qualitative evidence synthesis
NIHR Open Research, vol. 6, 4Contributions to Journals: Articles- [ONLINE] DOI:
Experiences of women from ethnic minorities and underserved, marginalised and disadvantaged groups in communicating with health professionals during antenatal care: An overview of qualitative systematic reviews
NIHR Open Research, vol. 6, no. 2Contributions to Journals: Articles- [ONLINE] DOI:
Digitally enabled therapy for chronic tic disorders and Tourette Syndrome: a systematic review and economic evaluation
Health Technology Assessment, vol. 30, no. 8Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Trifluridine-tipiracil with bevacizumab for treating metastatic colorectal cancer after 2 systemic treatments [ID6298]: NICE Single Technology Appraisal
Commissioned by National Institute for Health and Care Excellence (NICE). Aberdeen HTA GroupBooks and Reports: Commissioned Reports- [ONLINE]
What are the influences on women’s preferences and decision-making when planning mode of birth in high-income countries? A qualitative systematic review
AJOG Global Reports, vol. 5, no. 3, 100556Contributions to Journals: Articles- [ONLINE]
- [ONLINE] DOI:
- [OPEN ACCESS]
The regenerate study: A non-randomised feasibility study of an intervention to reduce anticholinergic burden in older patients
Geriatrics, vol. 9, no. 6, 152Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Alternatives to surveillance for persistent human papillomavirus after a positive cervical screen:: A systematic review and meta-analysis
European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 302, pp. 332-338Contributions to Journals: Articles- [ONLINE]
- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Automated devices for identifying peripheral arterial disease in people with leg ulceration: an evidence synthesis and cost-effectiveness analysis
Health Technology Assessment, vol. 28, no. 37, pp. i-xxv, 1-158Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
The effects and safety of testosterone replacement therapy for men with hypogonadism: The TestES evidence synthesis and economic evaluation
Health Technology Assessment, vol. 28, no. 43Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Fruquintinib for previously treated metastatic colorectal cancer [ID6274]: NICE Single Technology Appraisal
Commissioned by National Institute for Health and Care Excellence (NICE). Aberdeen HTA GroupBooks and Reports: Commissioned Reports- [ONLINE]
What is the impact of long-term COVID-19 on workers in healthcare settings? A rapid systematic review of current evidence
PloS ONE, vol. 19, no. 3 , e0299743Contributions to Journals: Review articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Cost-effectiveness of testosterone treatment utilising individual patient data from randomised controlled trials in men with low testosterone levels
Andrology, vol. 12, no. 3, pp. 477-486Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Ivosidenib for treating advanced cholangiocarcinoma with an IDH1 R132 mutation after 1 or more systemic treatments
National Institute for Health and Care Excellence (NICE). 20 pagesBooks and Reports: Commissioned Reports- [ONLINE]
- [ONLINE]
- [ONLINE]
Netarsudil-latanoprost for previously treated openangle glaucoma or ocular hypertension [ID1363]: NICE Single Technology Appraisal
Commissioned by National Institute for Health and Care Excellence (NICE). Aberdeen HTA GroupBooks and Reports: Commissioned Reports- [ONLINE]
- [ONLINE]
Clinical Predictors Of Symptomatic Benefit In Men With Low Testosterone During Testosterone Treatment Compared With Placebo:: Results Of Individual Patient And Aggregate Data Meta-analyses
Annual Meeting of the Endocrine Society 2023, bvad114.1704Contributions to Journals: Abstracts- [ONLINE] DOI:
Symptomatic benefits of testosterone treatment in patient subgroups: a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis
The Lancet Healthy Longevity, vol. 4, no. 10, pp. e561-e572Contributions to Journals: Articles- [ONLINE]
- [ONLINE] DOI:
- [OPEN ACCESS]
Deucravacitinib for treating moderate-to-severe plaque psoriasis
Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence. 155 pagesBooks and Reports: Commissioned Reports- [ONLINE]
- [ONLINE]
Secukinumab for Moderate-to-Severe Hidradenitis Suppurativa [ID4039]: NICE Single Technology Appraisal
Commissioned by National Institute for Health and Care Excellence (NICE). Aberdeen HTA GroupBooks and Reports: Commissioned Reports- [ONLINE]
- [ONLINE]
PMON260 Cost-Effectiveness of Testosterone Treatment for Men with Hypogonadism
Annual Meeting of the Endocrine Society 2022Contributions to Conferences: Posters- [ONLINE] DOI:
PMON258 Patient-Reported Outcomes for men with Hypogonadism and the Impact of Low Testosterone Levels: a review of measures
Annual Meeting of the Endocrine Society 2022Contributions to Conferences: Posters- [ONLINE] DOI:
Management of the first stage of convulsive status epilepticus in adults: a systematic review of current randomised evidence
Journal of Neurology, vol. 269, no. 7, pp. 3420-3429Contributions to Journals: Review articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Axicabtagene ciloleucel for treating relapsed or refractory diffuse large B-cell lymphoma after one systemic therapy
London: Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence. 128 pagesBooks and Reports: Commissioned Reports- [ONLINE]
- [ONLINE]
Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis
The Lancet Healthy Longevity, vol. 3, no. 6, pp. e381–393Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]